Results 1 to 10 of about 14,445,357 (297)
Risk of venous thromboembolism in association with factor V leiden in cancer patients – The EDITH case-control study [PDF]
PLoS ONE, 2018 Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation.
Cécile Tromeur +2 more
exaly +2 more sources
Factor V Leiden Mutation and Stroke
Pediatric Neurology Briefs, 2001 The association of the factor V Leiden mutation and cerebrovascular disorder (CVD) in children is reviewed and the clinical features of 8 children with cerebral palsy (CP) and the Leiden mutation are described from the National Institute of Neurological ...
J Gordon Millichap
doaj +2 more sources
Factor V Leiden Mutation and Neonatal Stroke
Pediatric Neurology Briefs, 1997 Three infants with familial factor V Leiden mutation and neonatal cerebrovascular disorders are reported from the Children’s Hospital of Philadelphia, PA.
J Gordon Millichap
doaj +2 more sources
FACTOR V LEIDEN AND THROMBOEMBOLISM [PDF]
Basrah Journal of Surgery, 2004 Zuhair Al-Barazanchi
doaj +2 more sources
Factor V Leiden Mutation in Cerebrovascular Disease
Clinical and Applied Thrombosis/Hemostasis, 2005 Several studies indicate a high prevalence of factor V Leiden mutation as the most frequent coagulation defect found in patients with venous thrombosis. The relationship between this mutation and cerebrovascular disease has not been established in adults.
Buyru, N +3 more
openaire +3 more sources
Factor V Leiden and Cardiopulmonary Bypass
The Journal of ExtraCorporeal Technology, 2015 We present a case of a patient with factor V Leiden with an antithrombin III activity of 67% who received a successful aortic valve replacement supported by cardiopulmonary bypass (CPB). A safe level of anticoagulation was achieved by monitoring activated clotting time (ACT) and heparin concentration ensuring adequate anticoagulation throughout the ...
Victor, Uppal +5 more
openaire +3 more sources
Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients [PDF]
Turkish Journal of Hematology, 2011 OBJECTIVE: Budd-Chiari syndrome is a multifactorial disease in which several prothrombotic disorders may predispose patients to the development of thrombosis at this uncommon location (hepatic veins). The aim of this study was to determine the prevalence
Tawhida Y. Abdel Ghaffar +7 more
doaj +4 more sources
Fator V de Leiden Factor V Leiden
Revista Brasileira de Hematologia e Hemoterapia, 2005 José M. P. Godoy
doaj +2 more sources
Factor V Leiden mutation: An added risk in single ventricle palliation
Annals of Pediatric Cardiology, 2012 We present the case report of a child with Factor V Leiden mutation who underwent Fontan procedure. Thromboembolism is a widely recognized complication of the Fontan procedure and its modifications. Factor V Leiden mutation, being a hypercoagulable state,
R Saileela +4 more
doaj +2 more sources
Association of Factor V Leiden G1691a in Women Suffering Repeated Abortions [PDF]
Minia Journal of Medical Research, 2020 Purpose: To assess the relationship of factor V leiden G1691A mutation as a risk factor for repeated pregnancy loss. The focus has been on factor V leiden G1691A mutation that may predispose women to microthrombosis during the stages of embryo ...
Khalid Salah +4 more
doaj +1 more source